Literature DB >> 20152771

The metabolic syndrome in cancer survivors.

Esther C de Haas1, Sjoukje F Oosting, Joop D Lefrandt, Bruce Hr Wolffenbuttel, Dirk Th Sleijfer, Jourik A Gietema.   

Abstract

The metabolic syndrome, as a cluster of cardiovascular risk factors, may represent an important connection between cancer treatment and its common late effect of cardiovascular disease. Insight into the aetiology of the metabolic syndrome after cancer treatment might help to identify and treat cancer survivors with increased cardiovascular risk. In this review, we summarise current knowledge on the prevalence and pathophysiology of the metabolic syndrome in cancer survivors, and discuss current intervention strategies with an emphasis on new developments. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Year:  2010        PMID： 20152771     DOI： 10.1016/S1470-2045(09)70287-6

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


  62 in total

1.  Hispanic ethnicity as a moderator of the effects of aerobic and resistance exercise in survivors of breast cancer.

Authors:  Christina M Dieli-Conwright; Frank C Sweeney; Kerry S Courneya; Debu Tripathy; Nathalie Sami; Kyuwan Lee; Thomas A Buchanan; Darcy Spicer; Leslie Bernstein; Joanne E Mortimer; Wendy Demark-Wahnefried
Journal:  Cancer       Date:  2018-11-30       Impact factor: 6.860

Review 2.  Insights into the relationships between diabetes, prediabetes, and cancer.

Authors:  Lorenzo Scappaticcio; Maria Ida Maiorino; Giuseppe Bellastella; Dario Giugliano; Katherine Esposito
Journal:  Endocrine       Date:  2016-12-31       Impact factor: 3.633

3.  Unhealthy diets: a common soil for the association of metabolic syndrome and cancer.

Authors:  Katherine Esposito; Fortunato Ciardiello; Dario Giugliano
Journal:  Endocrine       Date:  2014-01-10       Impact factor: 3.633

4.  Asymptomatic cardiac toxicity in long-term cancer survivors: defining the population and recommendations for surveillance.

Authors:  Joseph R Carver; Dava Szalda; Bonnie Ky
Journal:  Semin Oncol       Date:  2013-04       Impact factor: 4.929

Review 5.  Energy balance and metabolism after cancer treatment.

Authors:  Emily S Tonorezos; Lee W Jones
Journal:  Semin Oncol       Date:  2013-12       Impact factor: 4.929

6.  Metabolic syndrome and the risk of colorectal cancer: a systematic review and meta-analysis.

Authors:  Xiaoding Shen; Yong Wang; Rui Zhao; Qianyi Wan; Yutao Wu; Lihao Zhao; Xiaoting Wu
Journal:  Int J Colorectal Dis       Date:  2021-07-31       Impact factor: 2.571

Review 7.  Cardiovascular imaging in cardio-oncology.

Authors:  Amir Abbas Mahabadi; Christoph Rischpler
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

Review 8.  Long-term Toxicity of Cancer Treatment in Older Patients.

Authors:  Armin Shahrokni; Abraham J Wu; Jeanne Carter; Stuart M Lichtman
Journal:  Clin Geriatr Med       Date:  2015-10-13       Impact factor: 3.076

9.  Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomes.

Authors:  Anuradha Budhu; Stephanie Roessler; Xuelian Zhao; Zhipeng Yu; Marshonna Forgues; Junfang Ji; Edward Karoly; Lun-Xiu Qin; Qing-Hai Ye; Hu-Liang Jia; Jia Fan; Hui-Chuan Sun; Zhao-You Tang; Xin Wei Wang
Journal:  Gastroenterology       Date:  2013-01-31       Impact factor: 22.682

10.  Exercise after diagnosis and metabolic syndrome among breast cancer survivors: a report from the Shanghai Breast Cancer Survival Study.

Authors:  Ping-Ping Bao; Ying Zheng; Sarah Nechuta; Kai Gu; Hui Cai; Peng Peng; Xiao-Ou Shu; Wei Lu
Journal:  Cancer Causes Control       Date:  2013-07-17       Impact factor: 2.506
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.